![Dmitri V. Lissin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dmitri V. Lissin
Direttore Tecnico/Scientifico/R&S presso SCILEX HOLDING COMPANY
Profilo
Dmitri V.
Lissin is currently the Director & Chief Medical Officer at Semnur Pharmaceuticals, Inc. He is also the Chief Medical Officer & Senior Vice President at Scilex, Inc. and Scilex Holding Co. Previously, he served as the Vice President-Clinical Development at XenoPort, Inc. from 2011 to 2015.
Dr. Lissin holds a doctorate degree from the Russian National Research Medical University.
Posizioni attive di Dmitri V. Lissin
Società | Posizione | Inizio |
---|---|---|
SCILEX HOLDING COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Semnur Pharmaceuticals, Inc.
![]() Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Direttore Tecnico/Scientifico/R&S | 01/07/2015 |
Scilex, Inc.
![]() Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
Precedenti posizioni note di Dmitri V. Lissin
Società | Posizione | Fine |
---|---|---|
XENOPORT, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2015 |
Formazione di Dmitri V. Lissin
Russian National Research Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Aziende private | 3 |
---|---|
Semnur Pharmaceuticals, Inc.
![]() Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
Scilex, Inc.
![]() Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
XenoPort, Inc.
![]() XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Dmitri V. Lissin